The CRISPR gene editing technique has had a dramatic influence on biomedical research, and has even been applied to a few ...

The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to new findings. The ...

CRISPR Therapeutics (NASDAQ: CRSP) works in the cutting-edge space of gene editing. The biotech company uses the CRISPR/Cas9 technique, which involves cutting DNA at a certain point and letting a ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...

Argininosuccinate lyase deficiency (ASLD), also known as argininosuccinic aciduria, is a disease that has been enriched in the Finnish genetic heritage. In this severe metabolic disease, the body does ...

CRISPR-Cas9 gene editing relies on a guide RNA that binds to a desired DNA sequence and a Cas9 enzyme that cuts both strands of DNA at that site, creating a double-strand break. Scientists edit the ...

The CRISPR family’s most versatile member has made its medical debut: a cutting-edge gene-editing technique known as prime editing has been used to treat a person for the first time. The recipient is ...

CRISPR Therapeutics expects regulatory decisions soon for what would be its first commercialized product. An approval would represent a vote of confidence in the technology CRISPR uses throughout its ...

Non-alcoholic fatty liver disease (NAFLD) is characterized by an excessive accumulation of lipids in hepatocytes in non-alcoholic individuals. NAFLD progressively changes from fatty liver to ...

A new study describes a key molecular mechanism that explains how cells exchange information through extracellular vesicles.